Q3 Recap: Apple Inc. (AAPL) Was One of This Billionaire’s Big Sells

TUDOR INVESTMENT CORPApple Inc. (NASDAQ:AAPL) was Paul Tudor Jones and Tudor Investment’s fourth largest 2Q 13F holding and its single largest public stock holding, but during 3Q, Tudor dumped over 90% of its shares, sending Apple down to 59th place. Tudor was doing plenty of buying and selling, shaking up his portfolio across the board in 3Q, much as he has done in previous quarters. Tudor does invest with a traders mentality, one that has proved quite successful. Thanks to his success, Tudor has the ability to charge above average fees – charging a 4% management fee on AUM and 23% performance fee – versus the typical 2-and-20 structure.

Apple Inc. (NASDAQ:AAPL) is down over 15% since the end of 3Q as the luster of the stock appears to have wore off. By all accounts the tech giant appears cheap on a valuation basis, trading at 13x earnings, compared other industry giants Microsoft (15x) and Google (22x). The company’s five year EPS growth run has been impressive, growing 70% annually, but its $500 billion market cap leads to growth concerns.

The expected growth rate for the next five years is a mere 22% annually. Despite launching a new iPad, iPhone and iPad mini this year, the stock remains pressured. We see the increasing rate for product introduction into the market as a downside that puts margin pressures on the company. Although it would appear that there is little middle ground for an investors – being either a love or hate – we would rather sit on the sidelines with Tudor for now. Apple also saw big selloffs from other top funds Samlyn Capital and Renaissance Technologies, of 80% and 60% respectively. Regardless of Tudor and other top managers’ disinterest, Apple was still the top stock pick for hedge funds last quarter, in aggregate terms.

Johnson & Johnson (NYSE:JNJ) was a new 2Q position for Tudor, but the fund lost interest quickly last quarter, dumping 98% of its shares – dropping Johnson and Johnson from Tudor’s 5th largest 13F holding to 292nd. We see valuation concerns for Johnson & Johnson and better investment opportunities as a reason to look elsewhere. Johnson & Johnson trades in line on a profit margin basis with major drug producers Merck and Pfizer, but carries an almost 20% premium to these peers on a trailing P/E basis at 23x. The drug maker also pays one of the lower dividends in terms of drug companies at a 3.5% yield.

McKesson Corporation (NYSE:MCK) was another stock that Tudor quickly fell out of love with, much like Johnson & Johnson and Apple Inc. (NASDAQ:AAPL). His 2Q position was an increase in shares of 150%, but Tudor sold off 98% of its shares in Q3, putting the healthcare company down to 450th from 6th in Tudor’s 13F holdings. Revenues are expected to slow for McKesson in fiscal year 2013, with relatively flat growth. The recent acquisition of PSS World Medical should add around $0.15 to EPS next year, coupled with cost synergies topping $100 million over the long term. We believe the company is properly valued, trading in line with competitor AmerisourceBergen at 14x. Tudor saw few catalysts for the stock prior to the acquisition of PSS, but with the addition, the stock could be worth looking at based on future growth.

Express Scripts Holding Company (NASDAQ:ESRX) was one of the stocks that Tudor sold its entire position in. The fund took an essentially new position in the stock during 2Q that made it Tudor’s 11th largest 13F holding. Express Scripts’s recent Medco acquisition will lead to synergies, but will also bring the loss of a major contract for Medco with UnitedHealth. Other concerns for investors include management’s opinion of 2013 analyst estimates, labeling them ‘overly aggressive’. Consensus estimates put this year EPS growth at 25% and 14% next year. We believe the setbacks will continue for Express due to the Walgreen fallout.

V.F. Corporation (NYSE:VFC) was another stock that Tudor dumped all of its holdings in last quarter. In 2Q, Tudor had taken a new position that made VF its 16th largest 13F position. The apparel company’s shift to a more profitable Outdoor segment will hurt top line in the interim, should this winter be unusually warm again. VF is also working on integration of its Timberland acquisition which should add $1.10 to 2012 EPS, compared to the $0.60 it added in 2011. Check out whether V.F. is one of the best-in-industry apparel companies.

On the whole, it appears that the uncertainty in healthcare reform and how it will impact coverage and reimbursement rates may have played a role in Tudor’s decision to cut many of its pharma stocks. The other major selloff, Apple Inc. (NASDAQ:AAPL), is a product of growth concerns, while the selloff in VF might be a changing of the guard, so to speak, as competition in the apparel industry is undoubtedly heating up.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

The 10 Largest Armies in the World: Who Should We Be Afraid Of?

Best Warren Buffett Quotes on Money You Need to Hear

The 10 Highest Suicide Rates by Profession

The 20 Most Underrated Movies of All Time

The 10 Fastest Growing Companies in America

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!